{
     "PMID": "26748256",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20161213",
     "LR": "20161230",
     "IS": "1872-7549 (Electronic) 0166-4328 (Linking)",
     "VI": "302",
     "DP": "2016 Apr 1",
     "TI": "Oral administration of d-galactose induces cognitive impairments and oxidative damage in rats.",
     "PG": "35-43",
     "LID": "10.1016/j.bbr.2015.12.041 [doi] S0166-4328(15)30350-8 [pii]",
     "AB": "d-Galactose (d-gal) is a reducing sugar that can be used to mimic the characteristics of aging in rodents; however, the effects of d-gal administration by oral route are not clear. Therefore, the aim of this study was to elucidate if the oral administration of d-gal induces cognitive impairments, neuronal loss, and oxidative damage, mimicking an animal model of aging. Male adult Wistar rats (4 months old) received d-gal (100mg/kg) via the oral route for a period of 1, 2, 4, 6 or 8 weeks. The results showed cognitive impairments in the open-field test in the 4th and 6th weeks after d-gal administration, as well as an impairment in spatial memory in the radial maze test after the 6th week of d-gal administration. The results indicated increase of levels of thiobarbituric acid reactive species-TBARS-and carbonyl group content in the prefrontal cortex from the 4th week, and in all weeks of d-gal administration, respectively. An increase in the levels of TBARS and carbonyl group content was observed in the hippocampus over the entire period of d-gal treatment. In the 8th week of d-gal administration, we also observed reductions in synaptophysin and TAU protein levels in the prefrontal cortex. Thus, d-gal given by oral route caused cognitive impairments which were accompanied by oxidative damage. Therefore, these results indicate that orally administered d-gal can induce the behavioral and neurochemical alterations that are observed in the natural aging process. However, oral d-gal effect in rats deserve further studies to be better described.",
     "CI": [
          "Copyright (c) 2015 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Budni, Josiane",
          "Pacheco, Robson",
          "da Silva, Sabrina",
          "Garcez, Michelle Lima",
          "Mina, Francielle",
          "Bellettini-Santos, Tatiani",
          "de Medeiros, Jesiel",
          "Voss, Bruna Constantino",
          "Steckert, Amanda Valnier",
          "Valvassori, Samira da Silva",
          "Quevedo, Joao"
     ],
     "AU": [
          "Budni J",
          "Pacheco R",
          "da Silva S",
          "Garcez ML",
          "Mina F",
          "Bellettini-Santos T",
          "de Medeiros J",
          "Voss BC",
          "Steckert AV",
          "Valvassori Sda S",
          "Quevedo J"
     ],
     "AD": "Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Laboratorio de Doencas Neurodegenerativas, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Electronic address: josiane.budni@unesc.net. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Laboratorio de Doencas Neurodegenerativas, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Laboratorio de Doencas Neurodegenerativas, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Laboratorio de Doencas Neurodegenerativas, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Laboratorio de Doencas Neurodegenerativas, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Laboratorio de Doencas Neurodegenerativas, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Laboratorio de Doencas Neurodegenerativas, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Laboratorio de Doencas Neurodegenerativas, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Laboratorio de Sinalizacao Neural e Psicofarmacologia, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Translational Psychiatry Program, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston (UTHealth), McGovern Medical School, Houston, TX, USA; Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA; Neuroscience Graduate Program, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20151231",
     "PL": "Netherlands",
     "TA": "Behav Brain Res",
     "JT": "Behavioural brain research",
     "JID": "8004872",
     "RN": [
          "0 (Synaptophysin)",
          "0 (Thiobarbituric Acid Reactive Substances)",
          "0 (tau Proteins)",
          "X2RN3Q8DNE (Galactose)"
     ],
     "SB": "IM",
     "MH": [
          "Administration, Oral",
          "Animals",
          "Brain/drug effects/metabolism/pathology",
          "Cognition Disorders/*chemically induced/*metabolism/pathology",
          "Disease Models, Animal",
          "Exploratory Behavior/drug effects",
          "Follow-Up Studies",
          "Galactose/*administration & dosage/pharmacology",
          "Male",
          "Maze Learning/drug effects",
          "Oxidative Stress/*drug effects",
          "Protein Carbonylation/drug effects",
          "Rats",
          "Rats, Wistar",
          "Reaction Time/drug effects",
          "Synaptophysin/metabolism",
          "Thiobarbituric Acid Reactive Substances/metabolism",
          "Time Factors",
          "tau Proteins/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Aging",
          "Cognitive impairment",
          "Oral d-galactose",
          "Oxidative damage"
     ],
     "EDAT": "2016/01/10 06:00",
     "MHDA": "2016/12/15 06:00",
     "CRDT": [
          "2016/01/10 06:00"
     ],
     "PHST": [
          "2015/08/27 00:00 [received]",
          "2015/12/20 00:00 [revised]",
          "2015/12/25 00:00 [accepted]",
          "2016/01/10 06:00 [entrez]",
          "2016/01/10 06:00 [pubmed]",
          "2016/12/15 06:00 [medline]"
     ],
     "AID": [
          "S0166-4328(15)30350-8 [pii]",
          "10.1016/j.bbr.2015.12.041 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Behav Brain Res. 2016 Apr 1;302:35-43. doi: 10.1016/j.bbr.2015.12.041. Epub 2015 Dec 31.",
     "term": "hippocampus"
}